Blankinship & Foster’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Blankinship & Foster's ABBV Position: Q3 2026 in Review
Blankinship & Foster reduced its AbbVie (ABBV) stake by 6.4% in Q3 2026, selling an estimated $251K and leaving 14,417 shares worth $3.77M. The position accounts for 0.77% of the portfolio, ranked #15.
Blankinship & Foster first reported a position in ABBV in Q3 2020 and has held it in 25 quarters since. The position peaked at $3.87M in Q2 2026. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Blankinship & Foster held 14,417 shares of AbbVie worth $3.77M as of Q3 2026.
- Blankinship & Foster sold 980 AbbVie shares in Q3 2026, an estimated $251K.
- AbbVie made up 0.77% of Blankinship & Foster's portfolio in Q3 2026, its #15 holding.
- Blankinship & Foster first reported a position in AbbVie in Q3 2020 and has held it in 25 quarters since.
- Blankinship & Foster's AbbVie position peaked at $3.87M in Q2 2026.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Blankinship & Foster's 13F filing for Q3 2026, filed 19 Oct 2026.